MiR-20a, a novel promising biomarker to predict prognosis in human cancer: a meta-analysis

[1]  Luyao Zhang,et al.  Knockdown of MiR-20a Enhances Sensitivity of Colorectal Cancer Cells to Cisplatin by Increasing ASK1 Expression , 2018, Cellular Physiology and Biochemistry.

[2]  L. Dubois,et al.  Prognostic Role of Hypoxia-Inducible Factor-2α Tumor Cell Expression in Cancer Patients: A Meta-Analysis , 2018, Front. Oncol..

[3]  Guoan Chen,et al.  Effects of microRNA-20a on the proliferation, migration and apoptosis of multiple myeloma via the PTEN/PI3K/AKT signaling pathway. , 2018, Oncology letters.

[4]  Yang Liu,et al.  MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  Yu Hu,et al.  Prognostic role of RDW in hematological malignancies: a systematic review and meta-analysis , 2018, Cancer Cell International.

[6]  Fan Zhou,et al.  Downregulation of leucine‐rich repeats and immunoglobulin‐like domains 1 by microRNA‐20a modulates gastric cancer multidrug resistance , 2018, Cancer science.

[7]  N. Cirillo,et al.  Predictive Prognostic Value of Tissue-Based MicroRNA Expression in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-analysis , 2018, Journal of dental research.

[8]  Chunzheng Gao,et al.  miRNA-20a upregulates TAK1 and increases proliferation in osteosarcoma cells. , 2018, Future oncology.

[9]  Xiaoxiao Xu,et al.  High circulating miR‐18a, miR‐20a, and miR‐92a expression correlates with poor prognosis in patients with non‐small cell lung cancer , 2017, Cancer medicine.

[10]  Weimin Fan,et al.  A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance , 2017, Cell Death and Differentiation.

[11]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[12]  E. Kleinerman,et al.  miR-20a Regulates FAS Expression in Osteosarcoma Cells by Modulating FAS Promoter Activity and Can be Therapeutically Targeted to Inhibit Lung Metastases , 2017, Molecular Cancer Therapeutics.

[13]  Yu-Feng Li,et al.  MicroRNA-20a contributes to cisplatin-resistance and migration of OVCAR3 ovarian cancer cell line. , 2017, Oncology letters.

[14]  J. Ma,et al.  Targeting of miR-20a against CFLAR to potentiate TRAIL-induced apoptotic sensitivity in HepG2 cells. , 2017, European review for medical and pharmacological sciences.

[15]  P. Dong,et al.  iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling , 2017, Journal of experimental & clinical cancer research : CR.

[16]  Jing Zhong,et al.  Serum miR-20a is a promising biomarker for gastric cancer. , 2017, Biomedical reports.

[17]  Qiang Zheng,et al.  Prognostic role of microRNAs in human gastrointestinal cancer: A systematic review and meta-analysis , 2017, Oncotarget.

[18]  G. Fuller,et al.  Serum microRNA profiling in patients with glioblastoma: a survival analysis , 2017, Molecular Cancer.

[19]  T. Song,et al.  MicroRNA-20a-5p targets RUNX3 to regulate proliferation and migration of human hepatocellular cancer cells. , 2016, Oncology reports.

[20]  M. Trivella,et al.  Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders. , 2016, The Cochrane database of systematic reviews.

[21]  S. Cai,et al.  MiR-20a-5p represses multi-drug resistance in osteosarcoma by targeting the KIF26B gene , 2016, Cancer Cell International.

[22]  J. Xu,et al.  miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD. , 2016, Molecular medicine reports.

[23]  J. Qu,et al.  MicroRNA-17-92 regulates myoblast proliferation and differentiation by targeting the ENH1/Id1 signaling axis , 2016, Cell Death and Differentiation.

[24]  Zongguang Zhou,et al.  MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4 , 2016, Oncotarget.

[25]  X. Fei,et al.  A miRNAs panel promotes the proliferation and invasion of colorectal cancer cells by targeting GABBR1 , 2016, Cancer medicine.

[26]  Haitao Shan,et al.  MiR-20a and miR-20b negatively regulate autophagy by targeting RB1CC1/FIP200 in breast cancer cells. , 2016, Life sciences.

[27]  W. Ge,et al.  HPV 16 E7 inhibits OSCC cell proliferation, invasion, and metastasis by upregulating the expression of miR-20a , 2016, Tumor Biology.

[28]  M. Vrabel.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses. , 2015, Oncology nursing forum.

[29]  Liyong Wu,et al.  Decreased expression of microRNA-20a promotes tumor progression and predicts poor prognosis of cutaneous squamous cell carcinoma. , 2015, International journal of clinical and experimental pathology.

[30]  Longhua Chen,et al.  MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma. , 2015, International journal of radiation oncology, biology, physics.

[31]  Yingyi Zhang,et al.  Inhibition of microRNA-17/20a suppresses cell proliferation in gastric cancer by modulating UBE2C expression. , 2015, Oncology reports.

[32]  Xiao-xia Hu,et al.  Meta-analysis of microRNA expression profiling studies in human cervical cancer , 2015, Medical Oncology.

[33]  Hein Putter,et al.  Comparison of stopped Cox regression with direct methods such as pseudo-values and binomial regression , 2015, Lifetime data analysis.

[34]  Daoyang Zhou,et al.  miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[35]  Fei Ren,et al.  MiR-20a Promotes Cervical Cancer Proliferation and Metastasis In Vitro and In Vivo , 2015, PloS one.

[36]  Ming Zhou,et al.  MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1 , 2014, Cancer biology & therapy.

[37]  Qing Yang,et al.  F-box protein FBXO31 is down-regulated in gastric cancer and negatively regulated by miR-17 and miR-20a , 2014, Oncotarget.

[38]  Tong Li,et al.  miR‐20a Promotes Prostate Cancer Invasion and Migration Through Targeting ABL2 , 2014, Journal of cellular biochemistry.

[39]  E. Kebebew,et al.  MiR-20a Is Upregulated in Anaplastic Thyroid Cancer and Targets LIMK1 , 2014, PloS one.

[40]  R. Liu,et al.  miRNA27a Is a Biomarker for Predicting Chemosensitivity and Prognosis in Metastatic or Recurrent Gastric Cancer , 2014, Journal of cellular biochemistry.

[41]  Xiao-ling Xu,et al.  MicroRNA-17, microRNA-18a, and microRNA-19a are prognostic indicators in esophageal squamous cell carcinoma. , 2014, The Annals of thoracic surgery.

[42]  M. Kuo,et al.  MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma. , 2013, Oral oncology.

[43]  D. Yao,et al.  Aberrant expression of miR-20a and miR-203 in cervical cancer. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[44]  L. Zhong,et al.  Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma , 2013, Journal of experimental & clinical cancer research : CR.

[45]  Paul Hofman,et al.  Two Panels of Plasma MicroRNAs as Non-Invasive Biomarkers for Prediction of Recurrence in Resectable NSCLC , 2013, PloS one.

[46]  H. Qian,et al.  Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer. , 2012, Molecular medicine reports.

[47]  Fang Wang,et al.  miR‐20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells , 2012, FEBS letters.

[48]  Edith A Perez,et al.  MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer. , 2011, Trends in molecular medicine.

[49]  Antonio Alcaraz,et al.  MicroRNA in prostate, bladder, and kidney cancer: a systematic review. , 2011, European urology.

[50]  Enrica Calura,et al.  Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections. , 2011, The Lancet. Oncology.

[51]  Xin Li,et al.  miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines. , 2011, Acta biochimica et biophysica Sinica.

[52]  A. Stang.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.

[53]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[54]  Fedor V. Karginov,et al.  The miR-17∼92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma , 2009, Proceedings of the National Academy of Sciences.

[55]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[56]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[57]  M. Sydes,et al.  Practical methods for incorporating summary time-to-event data into meta-analysis , 2007, Trials.

[58]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[59]  V. Ambros,et al.  An Extensive Class of Small RNAs in Caenorhabditis elegans , 2001, Science.

[60]  L. Lim,et al.  An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans , 2001, Science.

[61]  Tongshan Wang,et al.  miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB , 2015, Tumor Biology.

[62]  Jianyi Li,et al.  Differential distribution of miR-20a and miR-20b may underly metastatic heterogeneity of breast cancers. , 2012, Asian Pacific journal of cancer prevention : APJCP.